NIKKEI 225
37,646.67 +18.19 (+0.05%) HANG SENG
17,284.54 0.00 (0.00%) CRUDE OIL
83.88 +0.31 (+0.37%) GOLD FUTURES
2,339.80 -2.70 (-0.12%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,249.13 -331.12 (-0.64%)
The Carlyle Group L.P. (CG)
After hours:
| Previous close | 46.12 |
| Open | 45.36 |
| Bid | 45.60 x 300 |
| Ask | 45.63 x 300 |
| Day's range | 44.65 - 45.75 |
| 52-week range | 25.20 - 48.52 |
| Volume | |
| Avg. volume | 2,311,606 |
| Market cap | 16.569B |
| Beta (5Y monthly) | 1.78 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.40 (3.04%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- GlobeNewswire
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (“Carlyle Secured Lending”) (NASDAQ: CGBD) will host a conference call at 11:00 a.m. EST on Wednesday, May 8, 2024 to announce its first quarter ended March 31, 2024 financial results. A news release containing the quarterly results will be issued after market close on Tuesday, May 7, 2024. The conference call will be available via public webcast via a link on Carlyle Secured Lending’s website at carlylesecuredlending.com
- Business Wire
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
LONDON & BOSTON & TEL AVIV, Israel, April 01, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248). Teva and Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today also announced a strategic development funding agreement in which Abingworth provides Tev
- GlobeNewswire
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
Grant Christie Joins Acentra Health Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Grant Christie as Senior Vice President, Market Strategy and Solutions. MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelera
